Estimates Revisions Harvard Bioscience, Inc.
Stocks
HBIO
US4169062043
Advanced Medical Equipment & Technology
|
Delayed
Nasdaq
14:56:49 2026-08-19 EDT
|
5-day change | 1st Jan Change | ||
| 7.076 USD | +1.53% |
|
+14.69% | +5.81% |
| 08-11 | Harvard Bioscience, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| 08-11 | Harvard Bioscience, Inc., Q2 2026 Earnings Call, Aug 11, 2026 |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
- Stock Market
- Stocks
- HBIO Stock
- Consensus Harvard Bioscience, Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
